Forest Labs Spends $3B For Specialty Pharma Co. Aptalis
Forest Laboratories Inc. will buy Aptalis Holdings Inc. from TPG Capital LP for $2.9 billion, the companies said Wednesday, in a deal Forest said would help both companies in their continued...To view the full article, register now.
Already a subscriber? Click here to view full article